Roble Belko & Company’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87M Buy
118,468
+35,097
+42% +$849K 0.31% 38
2026
Q1
$2.02M Buy
83,371
+62,370
+297% +$1.51M 0.26% 44
2025
Q4
$510K Buy
21,001
+4,110
+24% +$99.9K 0.07% 82
2025
Q3
$411K Buy
16,891
+1,026
+6% +$24.9K 0.06% 80
2025
Q2
$385K Hold
15,865
0.06% 84
2025
Q1
$384K Hold
15,865
0.06% 83
2024
Q4
$380K Buy
15,865
+1,466
+10% +$35.3K 0.06% 85
2024
Q3
$351K Buy
14,399
+746
+5% +$18K 0.06% 85
2024
Q2
$324K Hold
13,653
0.05% 86
2024
Q1
$325K Hold
13,653
0.06% 86
2023
Q4
$327K Buy
13,653
+1,539
+13% +$35.9K 0.06% 74
2023
Q3
$280K Buy
12,114
+2,335
+24% +$54.5K 0.06% 75
2023
Q2
$230K Hold
9,779
0.05% 79
2023
Q1
$233K Hold
9,779
0.05% 85
2022
Q4
$229K Hold
9,779
0.05% 89
2022
Q3
$225K Hold
9,779
0.05% 84
2022
Q2
$233K Hold
9,779
0.05% 88
2022
Q1
$244K Hold
9,779
0.05% 93
2021
Q4
$260K Hold
9,779
0.05% 87
2021
Q3
$264K Hold
9,779
0.05% 75
2021
Q2
$265K Hold
9,779
0.06% 81
2021
Q1
$261K Hold
9,779
0.06% 75
2020
Q4
$270K Hold
9,779
0.07% 71
2020
Q3
$265K Hold
9,779
0.08% 71
2020
Q2
$264K Buy
9,779
+7,493
+328% +$195K 0.08% 73
2020
Q1
$56K Buy
2,286
+801
+54% +$20.7K 0.02% 141
2019
Q4
$39K Buy
+1,485
New +$38.5K 0.01% 164

Other funds holding IBDS

Roble Belko & Company's IBDS Position: Q2 2026 in Review

Roble Belko & Company increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 42% in Q2 2026, buying an estimated $849K and bringing the position to 118,468 shares worth $2.87M. The position accounts for 0.31% of the portfolio, ranked #38.

Roble Belko & Company first reported a position in IBDS in Q4 2019 and has held it in 27 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Roble Belko & Company held 118,468 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $2.87M as of Q2 2026.
  • Roble Belko & Company bought 35,097 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $849K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.31% of Roble Belko & Company's portfolio in Q2 2026, its #38 holding.
  • Roble Belko & Company first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2019 and has held it in 27 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.